Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway

Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway

A novel kefir exopolysaccharides (KEPS) derived from kefir grain fermentation were found to have a small molecular weight (12 kDa) compared to the traditionally high molecular weight (12,000 kDa) of kefiran (KE). KE has been shown to possess antioxidant, blood pressure-lowering, and immune-modulatin...

Full description

Bibliographic Details
Main Authors: Chun-Huei Liao, Chih-Ching Yen, Hsiao-Ling Chen, Yu-Hsien Liu, Yu-Hsuan Chen, Ying-Wei Lan, Ke-Rong Chen, Wei Chen, Chuan-Mu Chen
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Antioxidants
Subjects:
kefir exopolysaccharides
LPS
NF-κB
MAPK
IL-6
transgenic mice
Online Access:https://www.mdpi.com/2076-3921/12/9/1724

Internet

https://www.mdpi.com/2076-3921/12/9/1724

Similar Items